Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Healthcare Industry News Are Oral Contraceptives Safe? Discover the Benefits and Risks! Oral contraceptive pills, commonly known as birth control pills, rank second only to sterilization as a method of… byPallavi MadhirajuJuly 20, 2024